Paper Details

  1. Home
  2. Paper Details

Ocular hypotensive efficacy of bimatoprost 0.03% and travoprost 0.004% in patients with glaucoma or ocular hypertension.

Author: CantorLouis B, CortesArnold, HoopJoni, KnottsStephenie, WuDunnDarrell

Clinical TrialA clinical trial is a planned study conducted on humans to evaluate the efficacy and safety of pharmaceuticals, medical devices, and treatment methods. It aims to explore the possibilities of new treatments and improve the health of patients.
Comparative StudyResearch that compares multiple groups/interventions to determine differences/similarities in outcomes/characteristics.
Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
Randomized Controlled TrialA clinical trial that randomly assigns participants to treatment and control groups to evaluate the effects of an intervention.
Research Support, Non-U.S. Gov'tResearch funding provided by government agencies outside the United States.

Overview

This study compared the efficacy of bimatoprost and travoprost in lowering intraocular pressure (IOP) in patients with glaucoma or ocular hypertension. Both medications significantly reduced IOP after 6 months of treatment, but bimatoprost provided larger mean IOP reductions and more patients achieved low target pressures. Both medications were well tolerated.
Paper Details　
Original Abstract of the Article :
PURPOSE: To evaluate the IOP-lowering efficacy of bimatoprost and travoprost for the treatment of glaucoma and ocular hypertension. METHODS: Randomized, investigator-masked, parallel-group clinical trial. After completing a washout from all glaucoma medications, patients (n=26) were randomized to b...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://pubmed.ncbi.nlm.nih.gov/15016557

データ提供：米国国立医学図書館（NLM）

Tackling Marijuana Dependence: A New Frontier in Pharmacotherapy

The pursuit of effective treatments for substance dependence is a continuous quest, like searching for a hidden oasis in a vast and unforgiving desert. This research explores the potential of divalproex sodium, a medication commonly used for epilepsy and bipolar disorder, as a treatment option for marijuana dependence. The study, a double-blind, placebo-controlled pilot trial, delves into the feasibility and effectiveness of using divalproex sodium to address marijuana dependence, marking a significant step towards developing targeted pharmacological approaches for this condition.

Divalproex Sodium: A Potential Weapon Against Marijuana Dependence

Imagine a desert oasis where travelers seek solace and relief from the harsh conditions. This research investigates the potential of divalproex sodium to provide similar solace for individuals struggling with marijuana dependence. The study, akin to a carefully orchestrated exploration of the desert landscape, examines the feasibility and effectiveness of divalproex sodium as a treatment option. The findings suggest that divalproex sodium may offer a promising avenue for addressing marijuana dependence, opening new frontiers in pharmacotherapy for this condition.

Hope on the Horizon for Marijuana Dependence

The search for effective treatments for marijuana dependence is an ongoing journey, and this study offers a glimmer of hope on the horizon. The exploration of divalproex sodium as a potential pharmacotherapeutic option holds promise for developing targeted treatments for this condition. The research's findings encourage continued exploration and development of evidence-based approaches to address marijuana dependence, offering a path towards a more fulfilling life for individuals struggling with this condition.

Dr.Camel's Conclusion

The quest for effective treatments for substance dependence is a challenging journey, akin to navigating a vast and unforgiving desert. This study explores the potential of divalproex sodium as a pharmacotherapeutic option for marijuana dependence, offering a ray of hope on the horizon for individuals seeking to overcome this challenge. The research's findings encourage continued exploration and development of evidence-based approaches, paving the way for more effective treatments and a more fulfilling life for those struggling with marijuana dependence.

Date :
  1. Date Completed 2004-04-23
  2. Date Revised 2015-11-19
Further Info :

Pubmed ID

15016557

DOI: Digital Object Identifier

S0039625703001905

Related Literature

Article Analysis
・Effective treatment of glaucoma
SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.